A research team from the Anhui Institute of Optics and Fine Mechanics, the Hefei Institutes of Physical Science of the ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...

A team of researchers from the Max Born Institute (MBI) in Berlin and DESY in Hamburg has demonstrated a plasma lens capable ...

November 3, 2025) - IR-MED Ltd. (OTCQB: IRME) (the "Company" or "IR-Med"), a pioneer in artificial intelligence ("AI")-driven, non-invasive infrared spectrographic medical device developer, today ...

Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...

DexCom, Inc. , the global leader in glucose biosensing, today announced the appointment of Euan Ashley to its Board of Directors, effective October 24, 2025. Dr. Ashley is a renowned researcher, ...

About BMF-650 BMF-650 is an investigational, next-generation oral small-molecule GLP-1 RA being developed by Biomea Fusion for the treatment of obesity. Related to the broader orforglipron chemotype, ...

Photothermal AFM-IR is a highly effective method for nanoscale chemical analysis, ideally suited to the stringent requirements of semiconductor research and production. By integrating the spatial ...

Higher METS-IR is linked to increased risks of major cardiovascular events, heart failure, and mortality in T2D patients. The study found a dose-dependent relationship between METS-IR and ...

Please provide your email address to receive an email when new articles are posted on . Researchers presented a new subanalysis of the STRIDE trial. Ozempic improved walking distance in patients with ...

Abstract: Noninvasive blood glucose monitoring using infrared (IR) sensors represents a promising first step in treating diabetes and other blood sugar-related diseases. Traditional blood glucose ...